News
Valneva partners with Oxford Immunotec on T cell analysis for COVID-19 vaccine
Valneva has chosen UK-based diagnostics company Oxford Immunotec to perform T cell testing on participants receiving its COVID-19 vaccine candidate (VLA2001) in a Phase I/II study.